Young L S, Wormser G P
Kuzell Institute for Arthritis and Infectious Diseases, California Pacific Medical Center, San Francisco 94115.
Scand J Infect Dis Suppl. 1994;93:9-19.
The resurgence of tuberculosis has been documented in both developed and developing countries and is associated with the spread of human immunodeficiency virus (HIV) infection. In the USA, the steady decline in the incidence of tuberculosis witnessed during the past three decades has halted, and since early 1986, a resurgence of tuberculosis has been noted. A similar change in trend has occurred in the West, for example Britain and continental Europe. The present problem is aggravated by the emergence of multiply drug resistant (MDR) strains of Mycobacterium tuberculosis. While drug resistance is not a new phenomenon, it had not hitherto been experienced in combination with HIV infection. Previously, MDR tuberculosis was indolent, slowly progressive and usually restricted to the lungs. However, in the setting of an HIV-infected patient it is often systemic, aggressive, difficult to treat and associated with early mortality. In New York State, many of the population 'at risk' of contracting tuberculosis, as well as of HIV infection have been incarcerated. This provides a public health opportunity to intervene to prevent and treat both of these diseases.
结核病的再度流行在发达国家和发展中国家都有记载,并且与人类免疫缺陷病毒(HIV)感染的传播有关。在美国,过去三十年中结核病发病率稳步下降的趋势已经停止,自1986年初以来,已注意到结核病再度流行。西方也出现了类似的趋势变化,例如英国和欧洲大陆。目前的问题因多重耐药结核分枝杆菌菌株的出现而加剧。虽然耐药性不是一个新现象,但以前从未在与HIV感染同时出现的情况下发生过。以前,耐多药结核病发展缓慢、进展缓慢,通常局限于肺部。然而,在HIV感染患者中,它往往是全身性的、侵袭性的、难以治疗且与早期死亡率相关。在纽约州,许多有感染结核病以及HIV风险的人群都被监禁。这为干预预防和治疗这两种疾病提供了一个公共卫生机会。